Abstract
Positron-emission tomography (PET) is an important oncologic imaging tool for primary tumor staging, evaluation of treatment response, recurrence detection, and restaging. Combined with computed tomography (CT), PET/CT has increased the diagnostic accuracy and dramatically reduced the acquisition time. This article describes the normal uptake, distribution, and excretion of Fluorine-18-labeled deoxyglucose (l8F FDG) as well as normal variations, response to treatment regimes, artifacts, and potential pitfalls that are important for correct image interpretation of whole-body PET/CT in oncology.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 16-30 |
| Number of pages | 15 |
| Journal | Applied Radiology |
| Volume | 35 |
| Issue number | 6 |
| State | Published - Jun 1 2006 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging